Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - human coagulation factor viii; von willebrand factor -

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

csl behring s.a. - factor von willebrand; factor viii - polvo y disolvente para soluciÓn inyectable y para perfusiÓn - 600 ui/250 ui - factor von willebrand 600 ui; factor viii 250 ui - factor von willebrand y factor viii de la coagulación en combinación

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

csl behring s.a. - factor von willebrand; factor viii - polvo y disolvente para soluciÓn inyectable y para perfusiÓn - 2.400 ui/1.000 ui - factor von willebrand 2400 ui; factor viii 1000 ui - factor von willebrand y factor viii de la coagulación en combinación

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

csl behring s.a. - factor von willebrand; factor viii - polvo y disolvente para soluciÓn inyectable y para perfusiÓn - 1.200 ui/500 ui - factor von willebrand 1200 ui; factor viii 500 ui - factor von willebrand y factor viii de la coagulación en combinación

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - von willebrand factor, quantity: 800 iu; factor viii, quantity: 900 iu; factor viii, quantity: 15 mg - injection, powder for - excipient ingredients: calcium chloride dihydrate; glycine; sodium chloride; sucrose; octoxinol 9; tributyl phosphate; sodium citrate dihydrate - 1. von willebrand disease (vwd): treatment of bleeding episodes including surgical bleeding in patients with von willebrand's disease when desmopressin treatment is ineffective or contraindicated. 2. haemophilia a: treatment and prophylaxis of bleeding including surgical bleeding in patients with haemophilia a (congenital fviii deficiency). there are insuffcient data to recommend the use of wilate in children less than 12 years of age.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 500/500 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

Irland - engelsk - HPRA (Health Products Regulatory Authority)

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 1000/1000 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

csl behring gmbh - Коагуляционного фактора човек viii, фактор Виллебранда човек - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - Болестта Виллебранда (vwd)профилактика и лечение на кръвоизливи и хирургически кръвоизливи при пациенти с vwd, когато Десмопрессин (ddavp) е един за лечение са неефективни или противопоказани. Хемофилия в (вроден фактор viii вида недостатъчност)профилактика и лечение на кръвоизливи при пациенти с хемофилия А.

Den europeiske union - norsk - EMA (European Medicines Agency)

csl behring gmbh - menneskelige koagulering faktor viii, human von willebrand faktor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand sykdom (vwd)prophylaxis og behandling av blødning eller kirurgisk blødning hos pasienter med vwd, når desmopressin (ddavp) behandling alene er ineffektiv eller kontraindisert. haemophilia a (medfødt faktor-viii-mangel)prophylaxis og behandling av blødninger hos pasienter med haemophilia en.

Den europeiske union - latvisk - EMA (European Medicines Agency)

csl behring gmbh - cilvēka koagulācijas viii faktora, cilvēku von willebrand faktora - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand slimības (vwd)profilaksei un ārstēšanai, asiņošanu vai ķirurģijas asiņošana pacientiem ar vwd, kad desmopressin (ddavp) ārstniecības vien ir neefektīvs vai kontrindicēta. hemofilijas a (iedzimts faktors-viii trūkums)profilaksei un ārstēšanai, asiņošanas pacientiem ar hemofilijas a.